Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 22

Results For "ISA"

1490 News Found

Apollo launches its 76th hospital, boosts tech-led healthcare in India
Hospitals | April 28, 2026

Apollo launches its 76th hospital, boosts tech-led healthcare in India

Hyderabad based 400-bed facility brings AI-driven care, advanced imaging, and integrated clinical systems under one roof


Sun Pharma eyes biosimilars-led growth, Organon deal to build $12.4 billion global platform
News | April 28, 2026

Sun Pharma eyes biosimilars-led growth, Organon deal to build $12.4 billion global platform

On the generics and biosimilars front, the combined business is expected to benefit from Sun’s portfolio of more than 550 approved ANDAs across multiple dosage forms


AbbVie seeks FDA nod for subcutaneous SKYRIZI induction in Crohn’s disease
Drug Approval | April 28, 2026

AbbVie seeks FDA nod for subcutaneous SKYRIZI induction in Crohn’s disease

The submission is backed by positive results from the Phase 3 AFFIRM study


Indian Immunologicals clocks all-time high revenue of Rs 1,586 crore in FY26
Biopharma | April 27, 2026

Indian Immunologicals clocks all-time high revenue of Rs 1,586 crore in FY26

Over the past decade, IIL has maintained a strong growth trajectory, registering a compound annual growth rate (CAGR) of 16%


Wellness travel is moving closer to home: What’s driving the shift?
Opinion | April 27, 2026

Wellness travel is moving closer to home: What’s driving the shift?

India leads the shift as wellness tourism integrates healthcare, hospitality, and lifestyle


Huwel Lifesciences, ASMS expand into Southeast Asia with Singapore partner
Supply Chain | April 27, 2026

Huwel Lifesciences, ASMS expand into Southeast Asia with Singapore partner

Collaboration to drive diagnostics exports, tap high-growth regional markets and build scalable commercialization platform


Tata AIA launches ‘Shubh Health Criti’ blending life cover with wellness and investments
Healthcare | April 27, 2026

Tata AIA launches ‘Shubh Health Criti’ blending life cover with wellness and investments

New plan integrates critical illness protection, market-linked health fund and preventive care platform for holistic financial and health security


IPC signs MoUs with PMBI, NIPER Hajipur to boost drug quality, pharmacovigilance and research collaboration
Policy | April 25, 2026

IPC signs MoUs with PMBI, NIPER Hajipur to boost drug quality, pharmacovigilance and research collaboration

The agreements aim to strengthen medicine quality, patient safety and pharmaceutical research in India


NIPER Hajipur, Boehringer Ingelheim India ink MoU to boost translational pharma research
Policy | April 25, 2026

NIPER Hajipur, Boehringer Ingelheim India ink MoU to boost translational pharma research

As part of the partnership, Boehringer Ingelheim will provide access to its opnMe® platform, enabling broader scientific exchange and driving innovation-led research.


India’s bio-economy to hit $1 trillion by 2047: Dr Jitendra Singh
Policy | April 25, 2026

India’s bio-economy to hit $1 trillion by 2047: Dr Jitendra Singh

At IIT Roorkee’s Vision 2047 conference, the union minister highlights BioE3 policy, rising biotech startups, and major scientific milestones